[ad_1]
(Reuters) – Unilever (NYSE 🙂 Plc talks with banks about additional financing for a potentially sweet offer for GlaxoSmithKline (NYSE 🙂 Plc’s consumer products division, Bloomberg reported at https://www.bloomberg.com / news / articles / 2022-01-16 / unilever-es-said-to-weigh-raising-offer-for-glaxo-consumer-unit? sref = WJKVI5nK on Sunday, citing people who know the subject.
Unilever and GSK did not immediately respond to Reuters’ comments.
GSK reported that Unilever had turned down a £ 50bn ($ 68.37bn) bid for a consumer goods weapon and the news came one day. GSK said it had received three offers from Unilever, the latest on December 20.
Unilever may eventually sell some non-core assets from GSK’s portfolio to private shareholders to internal buyers, which could help fund a purchase, the Bloomberg report added.
($ 1 = £ 0.73)
Fusion Media or anyone involved with Fusion Media will not be held liable for any loss or damage as a result of relying on the information contained in the data, estimates, charts and buy / sell signals contained in this website. Please be informed that one of the most risky forms of investment possible is the full information on the risks and costs associated with trading in the financial markets.
[ad_2]
Source link
